Jazz Pharmaceuticals (JAZZ)
Create an Alert
68.26
-1.40 -2.01%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Jazz Pharmaceuticals Cash and ST Investments:
450.51M for March 31, 2013Jazz Pharmaceuticals Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 450.51M |
| Dec. 31, 2012 | 387.20M |
| Sept. 30, 2012 | 189.79M |
| June 30, 2012 | 154.54M |
| March 31, 2012 | 244.22M |
| Dec. 31, 2011 | 157.90M |
| Sept. 30, 2011 | 113.35M |
| June 30, 2011 | 102.40M |
| March 31, 2011 | 65.06M |
| Dec. 31, 2010 | 44.79M |
| Sept. 30, 2010 | 22.85M |
| June 30, 2010 | 9.574M |
| March 31, 2010 | 19.00M |
| Dec. 31, 2009 | 15.60M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
JAZZ Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Santarus | 97.63M |
| Cubist Pharmaceuticals | 852.51M |
| Biogen Idec | 663.30M |
JAZZ Cash and ST Investments Rankings
| Overall |
88th percentile 1908 of 16782 |
| Sector |
91st percentile 115 of 1410 in Healthcare |
| Industry |
95th percentile 22 of 454 in Biotechnology |
JAZZ Cash and ST Investments Range, Past 5 Years
| Minimum | 9.574M | Jun 2010 |
| Maximum | 450.51M | Mar 2013 |
| Average | 107.57M |
